Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
Bronchopulmonary dysplasia Indication Strategy Report 2026: VEGF-A, Trials and Deals
21 July 2026
Bronchopulmonary dysplasia indication strategy report covering epidemiology, VEGF-A biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Acute respiratory distress syndrome Indication Strategy Report 2026: IL-6R, Trials and Deals
21 July 2026
Acute respiratory distress syndrome indication strategy report covering epidemiology, IL-6R biology, active trials, competition and deal signals using PatSnap...
Read →
Latest Hotspot
8 min read
Chronic obstructive pulmonary disease Indication Strategy Report 2026: PDE4B, Trials and Deals
21 July 2026
Chronic obstructive pulmonary disease indication strategy report covering epidemiology, PDE4B biology, active trials, competition and deal signals using PatSnap...
Read →
Latest Hotspot
8 min read
Bronchiectasis Indication Strategy Report 2026: DPP-1, Trials and Deals
21 July 2026
Bronchiectasis indication strategy report covering epidemiology, DPP-1 biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Allergic rhinitis Indication Strategy Report 2026: FCER1A, Trials and Deals
21 July 2026
Allergic rhinitis indication strategy report covering epidemiology, FCER1A biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Chronic rhinosinusitis with nasal polyps Indication Strategy Report 2026: IL-4Rα, Trials and Deals
21 July 2026
Chronic rhinosinusitis with nasal polyps indication strategy report covering epidemiology, IL-4Rα biology, active trials, competition and deal signals using...
Read →
Latest Hotspot
8 min read
Allergic asthma Indication Strategy Report 2026: IL-4Rα, Trials and Deals
21 July 2026
Allergic asthma indication strategy report covering epidemiology, IL-4Rα biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Eosinophilic asthma Indication Strategy Report 2026: IL-5, Trials and Deals
21 July 2026
Eosinophilic asthma indication strategy report covering epidemiology, IL-5 biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Severe asthma Indication Strategy Report 2026: TSLP, Trials and Deals
21 July 2026
Severe asthma indication strategy report covering epidemiology, TSLP biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Eosinophilic duodenitis Indication Strategy Report 2026: IL-5Rα, Trials and Whitespace
21 July 2026
Eosinophilic duodenitis indication strategy report covering epidemiology, IL-5Rα biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Eosinophilic gastritis Indication Strategy Report 2026: IL-5Rα, Trials and Deals
21 July 2026
Eosinophilic gastritis indication strategy report covering epidemiology, IL-5Rα biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Peanut allergy Indication Strategy Report 2026: FCER1A, Trials and Deals
21 July 2026
Peanut allergy indication strategy report covering epidemiology, FCER1A biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
<
1
<<
758
759
760
761
762
>>
1222
>